Thu Nguyen-Anh Tran

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 13

Top Topics

Drug Administration

Plasmodium Falciparum

Trypanosoma Cruzi

Top Venues

Nature communications

PLOS global public health

medRxiv : the preprint server for health sciences

Nature medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Eric Zhewen Li, Tran Dang Nguyen, Thu Nguyen-Anh Tran, Robert J Zupko, Maciej F Boni
Assessing emergence risk of double-resistant and triple-resistant genotypes of Plasmodium falciparum. Nature communications 15 (1) (2024)
Eric Zhewen Li, Tran Dang Nguyen, Thu Nguyen-Anh Tran, Robert J Zupko, Maciej F Boni
Assessing emergence risk of double-resistant and triple-resistant genotypes of Plasmodium falciparum. Nature communications 15 (1) (2024)
Eric Zhewen Li, Tran Dang Nguyen, Thu Nguyen-Anh Tran, Robert J Zupko, Maciej F Boni
Assessing emergence risk of double-resistant and triple-resistant genotypes of Plasmodium falciparum. Nature communications 15 (1) (2024)
Eric Zhewen Li, Tran Dang Nguyen, Thu Nguyen-Anh Tran, Robert J Zupko, Maciej F Boni
Assessing emergence risk of double-resistant and triple-resistant genotypes of Plasmodium falciparum. Nature communications 15 (1) (2024)
Eric Zhewen Li, Tran Dang Nguyen, Thu Nguyen-Anh Tran, Robert J Zupko, Maciej F Boni
Assessing emergence risk of double-resistant and triple-resistant genotypes of Plasmodium falciparum. Nature communications 15 (1) (2024)
Fuhan Yang, Thu Nguyen-Anh Tran, Emily Howerton, Maciej F Boni, Joseph L Servadio
Benefits of near-universal vaccination and treatment access to manage COVID-19 burden in the United States. medRxiv : the preprint server for health sciences (2023)
Tran Dang Nguyen, Bo Gao, Chanaki Amaratunga, Mehul Dhorda, Thu Nguyen-Anh Tran, Nicholas J White, Arjen M Dondorp, Maciej F Boni, Ricardo Aguas
Preventing antimalarial drug resistance with triple artemisinin-based combination therapies. Nature communications 14 (1) (2023)
Robert J Zupko, Tran Dang Nguyen, J Claude S Ngabonziza, Michee Kabera, Haojun Li, Thu Nguyen-Anh Tran, Kien Trung Tran, Aline Uwimana, Maciej F Boni
Modeling policy interventions for slowing the spread of artemisinin-resistant pfkelch R561H mutations in Rwanda. Nature medicine (2023)
Fuhan Yang, Thu Nguyen-Anh Tran, Emily Howerton, Maciej F Boni, Joseph L Servadio
Benefits of near-universal vaccination and treatment access to manage COVID-19 burden in the United States. medRxiv : the preprint server for health sciences (2023)
Tran Dang Nguyen, Thu Nguyen-Anh Tran, Daniel M Parker, Nicholas J White, Maciej F Boni
Antimalarial mass drug administration in large populations and the evolution of drug resistance. PLOS global public health 3 (7) (2023)
Nathan B Wikle, Thu Nguyen-Anh Tran, Bethany Gentilesco, Scott M Leighow, Emmy Albert, Emily R Strong, Karel Bå Inda, Haider Inam, Fuhan Yang, Sajid Hossain, Philip Chan, William P Hanage, Maria Messick, Justin R Pritchard, Ephraim M Hanks, Maciej F Boni
SARS-CoV-2 epidemic after social and economic reopening in three U.S. states reveals shifts in age structure and clinical characteristics. Science advances 8 (4) (2022)
Robert J Zupko, Tran Dang Nguyen, Anyirékun Fabrice Somé, Thu Nguyen-Anh Tran, Jaline Gerardin, Patrick Dudas, Dang Duy Hoang Giang, Kien Trung Tran, Amy Wesolowski, Jean-Bosco Ouedraogo, Maciej F Boni
Long-term effects of increased adoption of artemisinin combination therapies in Burkina Faso. PLOS global public health 2 (2) (2022)
Thu Nguyen-Anh Tran, Nathan B Wikle, Emmy Albert, Haider Inam, Emily Strong, Karel Brinda, Scott M Leighow, Fuhan Yang, Sajid Hossain, Justin R Pritchard, Philip Chan, William P Hanage, Ephraim M Hanks, Maciej F Boni
Optimal SARS-CoV-2 vaccine allocation using real-time attack-rate estimates in Rhode Island and Massachusetts. BMC medicine 19 (1) (2021)